South African medical aid members are facing another year of significant contribution increases, with the latest round of 2026 pricing changes from major schemes coming in well above headline inflation. The warning from the Council for Medical Schemes, or CMS, was that contribution growth has been outpacing consumer inflation for years, putting added pressure on already stretched household budgets.
That warning is now reflected in the actual numbers announced across the market. Discovery Health Medical Scheme has announced a weighted average increase of 7.2% for 2026, Bonitas 8.8%, Medihelp 8.46%, Bestmed 6.8%, and GEMS 9.8% for 2026. In each case, the increase sits materially above the inflation environment consumers have become used to over the past year.
CMS has already raised the alarm
The clearest regulatory warning came in CMS Circular 24 of 2025, which set out guidance for 2026 benefit changes. The regulator said annual medical scheme contribution rates have consistently risen faster than consumer inflation and described the trend as a significant financial burden on members, especially alongside electricity and food-cost pressures. CMS recommended that contribution increases and tariff assumptions for the 2026 benefit year be limited to 3.3% plus reasonable utilisation estimates.
That guidance matters because it shows the regulator was already concerned before the final scheme announcements landed. Yet the market has still produced increases that sit far above that 3.3% base, even after allowing for higher healthcare use and cost pressure. In practice, this means many households are once again facing medical aid increases that are likely to outstrip wage growth and ordinary inflation.
The 2026 increases are broad-based
Among the largest schemes, Discovery’s 7.2% weighted average increase is one of the lower announced hikes, although it deferred the effective date of its contribution increase to 1 April 2026, giving members three months of 2025-level premiums. Bonitas’ 8.8% increase took effect from 1 January 2026, while Medihelp said its weighted average increase is 8.46% and Bestmed said its average weighted increase is 6.8%.
The public sector has not been spared either. GEMS, one of the country’s most important restricted schemes, said member contributions for 2026 would increase by a weighted average of 9.8%, with the scheme stating that the adjustment was necessary for long-term sustainability. That is a meaningful development because GEMS affects a large base of public servants and their dependants, meaning the price pressure is not limited to private open-scheme members.
Why prices keep rising
The underlying explanation from the industry is that healthcare inflation is only part of the story. Discovery said its 2026 increase reflects not only the cost of healthcare products and services, but also rising utilisation, with higher use of healthcare services expected to add another 3% to 4% to claims. Medihelp similarly said its pricing reflects real claims trends, benefit design and the long-term sustainability of each plan.
CMS’s own industry data supports the broader pressure narrative. In its 2024 Industry Report, the regulator said the relevant healthcare expenditure ratio for all schemes increased to 96.18%, well above pre-pandemic levels, and said significant repricing and benefit adjustments are therefore needed. The same report said that for every R100 received in insurance revenue in 2024, schemes paid R96.18 in relevant healthcare expenditure and R6.89 in directly attributable insurance service expenditure, leaving a shortfall that had to be supported by other income such as investment returns.
That is one of the clearest reasons the affordability debate is becoming more difficult. Schemes are under pressure to keep contributions lower, but the regulator’s own numbers suggest many products are not building reserves through pricing alone. In simple terms, that means schemes are trying to balance affordability against sustainability in an environment where claims and healthcare use remain elevated.
The affordability squeeze is becoming harder to ignore
The bad news for members is that these increases are landing in a country where medical scheme cover is already limited to a relatively small share of the population. CMS’s 2024 Industry Report said the proportion of South Africans covered by medical schemes slipped to 14.6% of the population in 2024, down slightly from about 15% in 2000, largely because population growth outpaced scheme growth. Open schemes also declined by 1.31% between 2023 and 2024, while restricted schemes grew by 2.41%.
That trend suggests affordability remains a real barrier to entry and retention. When contribution increases stay ahead of inflation year after year, some households buy down to cheaper options, while others leave cover altogether. Southafriworld’s broader business news coverage has tracked similar cost pressures across transport, tax and household spending categories, and medical aid is now firmly part of that broader affordability story.
The inflation data shows how visible this pressure has become in the consumer basket. Stats SA said in March 2025 that medical aid premiums increased by 10.5% that year, slightly above the 10.3% rise recorded in 2024, while annual consumer inflation in February 2025 was only 3.2%. Although the 2026 contribution increases announced by several major schemes are lower than the steep premium shocks seen in early 2025, they still remain well above general inflation.
There is some tax relief, but not enough to offset the increases
National Treasury’s 2026 Budget offers a limited cushion rather than a full answer. Treasury said personal income tax brackets and medical tax credits would be fully adjusted for inflation after two years with no inflationary relief. The 2026 Budget tax guide shows the medical scheme fees tax credit rising to R376 per month for each of the first two beneficiaries and R254 for each additional dependant.
That will help some taxpayers on the margin, but it does not change the core problem facing medical aid members. Even with inflation-linked tax-credit relief, the actual contribution increases announced by schemes remain much higher than the tax adjustment itself. For many families, especially those covering several dependants, the net result will still be a higher out-of-pocket monthly healthcare bill in 2026.
What this means for members now
For medical aid users, the immediate reality is that 2026 has not brought a broad-based affordability breakthrough. Some schemes have tried to soften the blow through timing, plan design or lower increases on selected options, but the overall direction remains upward. The regulator’s concern that contribution increases are persistently running ahead of inflation has not gone away.
The bigger issue for the sector is whether affordability can be stabilised without undermining solvency and benefit quality. For now, the numbers suggest members should expect continued pressure, not relief. That is the central warning for South Africans who rely on private medical cover in 2026: medical aid remains essential for many households, but it is becoming harder to keep.
